These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31581902)

  • 1. Sociodemographic and clinical characteristics of synthetic cannabinoid users in a large psychiatric emergency department in Turkey.
    Yalçın M; Tunalı N; Yıldız H; Oğuz A; Gültekin BK
    J Addict Dis; 2018; 37(3-4):259-267. PubMed ID: 31581902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric Emergency Setting.
    Manseau MW; Rajparia A; Joseph A; Azarchi S; Goff D; Satodiya R; Lewis CF
    Subst Use Misuse; 2017 May; 52(6):822-825. PubMed ID: 28156305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting.
    Joseph AM; Manseau MW; Lalane M; Rajparia A; Lewis CF
    Am J Drug Alcohol Abuse; 2017 Jan; 43(1):117-122. PubMed ID: 27797288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study.
    Shalit N; Barzilay R; Shoval G; Shlosberg D; Mor N; Zweigenhaft N; Weizman A; Krivoy A
    J Clin Psychiatry; 2016 Aug; 77(8):e989-95. PubMed ID: 27379411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Chameleon-Like Properties of Psychoactive Drugs: Examinations with HR LC-MS/MS Technology of Patients Presenting at the Emergency Department Following the Use of Synthetic Cannabinoids: A Case Series and Literature Review.
    Altintop I; Karakukcu C
    Behav Sci (Basel); 2018 Sep; 8(10):. PubMed ID: 30248995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of synthetic cannabinoid-induced psychotic disorders: a single-center analysis of hospitalized patients.
    Skryabin VY; Vinnikova MA
    J Addict Dis; 2018; 37(3-4):135-141. PubMed ID: 31272306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
    Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
    J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic cannabinoid use in psychiatric patients and relationship to hospitalisation: A retrospective electronic case register study.
    Hobbs M; Patel R; Morrison PD; Kalk N; Stone JM
    J Psychopharmacol; 2020 Jun; 34(6):648-653. PubMed ID: 32108548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and financial implications of emergency department visits for synthetic marijuana.
    Rowley E; Benson D; Tiffee A; Hockensmith A; Zeng H; Jones GN; Musso MW
    Am J Emerg Med; 2017 Oct; 35(10):1506-1509. PubMed ID: 28457767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset.
    Martinotti G; Santacroce R; Papanti D; Elgharably Y; Prilutskaya M; Corazza O
    CNS Neurol Disord Drug Targets; 2017; 16(5):567-575. PubMed ID: 28412921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of violence, and the relationship with childhood trauma in Turkish men with alcohol, opiate, and synthetic cannabinoid use disorder.
    Ergelen M; Yalçın M; Bilici R
    Neuropsychiatr Dis Treat; 2018; 14():3169-3178. PubMed ID: 30538474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suspected Synthetic Cannabinomimetic Intoxication: Case Series and Review.
    Baum RA; Bailey A; Chan R; Blumenschein K
    J Pharm Pract; 2018 Apr; 31(2):238-243. PubMed ID: 28357892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study.
    Welter S; Lücke C; Lam AP; Custal C; Moeller S; Sörös P; Thiel CM; Philipsen A; Müller HHO
    Eur Addict Res; 2017; 23(4):182-193. PubMed ID: 28848170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical characteristics between meth/amphetamine and synthetic cathinone users presented to the emergency department.
    Weng TI; Chen HY; Chin LW; Chou HH; Wu MH; Chen GY; Chen JY; Shih CP; Lin CC; Fang CC
    Clin Toxicol (Phila); 2022 Aug; 60(8):926-932. PubMed ID: 35438590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Street drug use among emergency patients in a Public Hospital in Turkey.
    Caliskan FT; Toker I; Toktas R; Temizyurek Z; Unek O; Zirek B; Karcioglu O
    Niger J Clin Pract; 2018 Jan; 21(1):99-106. PubMed ID: 29411732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency physicians' knowledge of cannabinoid designer drugs.
    Lank PM; Pines E; Mycyk MB
    West J Emerg Med; 2013 Sep; 14(5):467-70. PubMed ID: 24106544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute intoxication caused by three common synthetic cannabinoids: The experience of a large, urban, tertiary care hospital.
    Shopan N; Scolnik D; Hassoun E; Firsow A; Volkov I; Glatstein M
    Am J Emerg Med; 2023 Nov; 73():7-10. PubMed ID: 37572408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.
    Mensen VT; Vreeker A; Nordgren J; Atkinson A; de la Torre R; Farré M; Ramaekers JG; Brunt TM
    Psychopharmacology (Berl); 2019 Sep; 236(9):2677-2685. PubMed ID: 30968175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of mental health and substance users in frequent users of a general Swiss emergency department.
    Vu F; Daeppen JB; Hugli O; Iglesias K; Stucki S; Paroz S; Canepa Allen M; Bodenmann P
    BMC Emerg Med; 2015 Oct; 15():27. PubMed ID: 26452550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.